We are live on
!
Find out more
LPC
Lion Point Capital Portfolio holdings
AUM
$16.7M
1-Year Est. Return
119.35%
This Fund
S&P 500
This Quarter
Est. Return
+50.48%
1 Year Est. Return
+119.35%
3 Year Est. Return
+204.43%
5 Year Est. Return
+220.32%
10 Year Est. Return
+1,396.08%
AUM
$412M
AUM Growth
+$33.4M
(+8.8%)
Cap. Flow
-$91M
Cap. Flow
% of AUM
-22.06%
Top 10 Holdings %
Top 10 Hldgs %
76.34%
Holding
28
New
3
Increased
2
Reduced
3
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TG Therapeutics
TGTX
|
+$14.5M |
| 2 |
ARNC
Arconic Corporation
ARNC
|
+$13.7M |
| 3 |
MRNS
Marinus Pharmaceuticals, Inc
MRNS
|
+$10.3M |
| 4 |
Liberty Global Class A
LBTYA
|
+$6.19M |
| 5 |
Spyre Therapeutics
SYRE
|
+$2.29M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lattice Semiconductor
LSCC
|
+$35.4M |
| 2 |
Howmet Aerospace
HWM
|
+$10.8M |
| 3 |
CPE
Callon Petroleum Company
CPE
|
+$4.49M |
| 4 |
DRRX
DURECT Corp
DRRX
|
+$1.98M |
| 5 |
XEC
CIMAREX ENERGY CO
XEC
|
+$591K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.95% |
| 2 | Healthcare | 30.59% |
| 3 | Energy | 7.93% |
| 4 | Communication Services | 6.76% |
| 5 | Materials | 4.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
PUT
iShares Russell 2000 ETF
IWM
$79.1B
| – | – |
-705,000
| Closed | -$80.7M |
|
|
CPE
27
DELISTED
Callon Petroleum Company
CPE
| – | – |
-820,271
| Closed | -$4.49M |
|
|
XEC
28
DELISTED
CIMAREX ENERGY CO
XEC
| – | – |
-35,162
| Closed | -$591K |
|
Similar funds
PA
SR
SCTC
SRA
CP
B
CVV
BCPE
Lion Point Capital's Q2 2020 Portfolio in Review
As of Q2 2020, Lion Point Capital held 28 positions worth $412M, up 8.8% from $379M the previous quarter. Its ten largest holdings account for 76% of the portfolio.
Lion Point Capital withdrew a net $91M in Q2 2020, closing 4 positions and reducing 3 holdings. Its most notable exit was Howmet Aerospace, an estimated $10.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Energy.
Against the trend, Lion Point Capital opened a new position in TG Therapeutics worth $17.5M.
- Lion Point Capital's largest Q2 2020 buy was TG Therapeutics: 897,799 shares worth $17.5M.
- Lion Point Capital added most to Marinus Pharmaceuticals, Inc in Q2 2020, an estimated $10.3M increase.
- Lion Point Capital's biggest Q2 2020 reduction was Lattice Semiconductor, cutting an estimated $35.4M.
- Lion Point Capital fully exited Howmet Aerospace in Q2 2020, selling an estimated $10.8M.
- Lion Point Capital's ten largest holdings make up 76% of its $412M portfolio in Q2 2020.
- Lion Point Capital opened 3 new positions and closed 4 in Q2 2020.
- Lion Point Capital's portfolio value rose 8.8% quarter-over-quarter to $412M.
Based on Lion Point Capital's 13F filing for Q2 2020, filed 14 Aug 2020.